πŸ‡ΊπŸ‡Έ FDA
Patent

US 8278458

Desferrithiocin polyether analogues

granted A61KA61K31/426A61P

Quick answer

US patent 8278458 (Desferrithiocin polyether analogues) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/426, A61P, A61P1/16, A61P3/00